Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Mar;27(3):487–496.

Antisera against leukaemia-associated antigens on human lymphocytes.

C C Hsu, G E Marti, K K Mittal
PMCID: PMC1540945  PMID: 301073

Abstract

Antisera were raised in rabbits against leukaemic lymphosarcoma (LSL) cells which carried surface markers of both thymus-derived T lymphocytes (T cells) and bone marrow-derived B lymphocytes (B cells). After absorption with leucocytes, erythrocytes and serum proteins from normal individuals, the antisera demonstrated significant complement-dependent cytotoxicity against leukaemic cells from patients with acute lymphoblastic leukaemia (ALL) (9/11), LSL (7/9) and chronic lymphocytic leukaemia (CLL) (9/12), with an antibody titre of 1:64 or greater. The antisera did not react with: (a) blood lymphocytes from clinically healthy individuals (0/23), patients with ono-lymphoproliferative disorders (0/8) and normal umbilical cords (0/3), (b) normal lymphocytes stimulated by pokeweed mitogen (0/7), allogeneic lymphocytes (0/3), fetuin (0/1), purified protein derivative (PPD) (0/2), and candida antigen (0/1); (C) normal marrow cells (0/3), (D) normal thymocytes (0/2) and (E) leukaemic cells from patients with acute myeloblastic (AML) (0/10) and chronic granulocytic leukaemia (CGL) (0/3). However, the antisera did react with lymphoblastoid cells from continuous B-cell lines derived from an AML patient and from a non-leukaemic individual and, to a lesser extent, with lymphocytes from patients with infectious mononucleosis. The antisera also reacted with lymphocytes from chronically infected tonsils. Cytotoxicity of the antisera against lymphoblastoid and tonsillar cells was inhibited by ALL and CLL cell-lysates; and, conversely, cytotoxicity against ALL cells was inhibited by the lymphoblastoid cell extract. In contrast, a cell lysate or extract from normal inhibited by the lymphoblastoid cell extract. In contrast, a cell lysate or extract from normal lymphocytes did not inhibit cytotoxicity toward lymphoblastoid, tonsillar or ALL cells. Cytotoxicity of the antisera was neutralized by a goat anti-rabbit IgG (GAR IgG). These results suggest that the antisera contained antibodies reactive with antigens possibly common to neoplastic lymphocytes, tonsillar cells, lymphoblastoid cells and some lymphocytes from patients with infectious mononucleosis.

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker M. A., Ramachandar K., Taub R. N. Specificity of heteroantisera to human acute leukemia-associated antigens. J Clin Invest. 1974 Dec;54(6):1273–1278. doi: 10.1172/JCI107872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bias W. B., Santos G. W., Burke P. J., Mullins G. M., Humphrey R. L. Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia. Science. 1972 Oct 20;178(4058):304–306. doi: 10.1126/science.178.4058.304. [DOI] [PubMed] [Google Scholar]
  3. Billing R. J., Terasaki P. I., Honig R., Peterson P. The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines. Lancet. 1976 Jun 26;1(7974):1365–1367. doi: 10.1016/s0140-6736(76)93022-1. [DOI] [PubMed] [Google Scholar]
  4. Billing R., Terasaki P. I. Human leukemia antigen. I. Production and characterization of antisera. J Natl Cancer Inst. 1974 Dec;53(6):1635–1638. [PubMed] [Google Scholar]
  5. Brown G., Capellaro D., Greaves M. Leukemia-associated antigens in man. J Natl Cancer Inst. 1975 Dec;55(6):1281–1289. doi: 10.1093/jnci/55.6.1281. [DOI] [PubMed] [Google Scholar]
  6. Chang R. S., Lewis J. P., Abildgaard C. F. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med. 1973 Dec 20;289(25):1325–1329. doi: 10.1056/NEJM197312202892501. [DOI] [PubMed] [Google Scholar]
  7. Cikes M. Variations in expression of surface antigens on cultured cells. Ann N Y Acad Sci. 1971 Jun 21;177:190–200. doi: 10.1111/j.1749-6632.1971.tb35046.x. [DOI] [PubMed] [Google Scholar]
  8. Dick H. M., Steel C. M., Crichton W. B. HL-A typing of cultured peripheral lymphoblastoid cells. Tissue Antigens. 1972;2(2):85–93. doi: 10.1111/j.1399-0039.1972.tb00122.x. [DOI] [PubMed] [Google Scholar]
  9. Edynak E. M., Old L. J., Vrana M., Lardis M. P. A fetal antigen associated with human neoplasia. N Engl J Med. 1972 Jun 1;286(22):1178–1183. doi: 10.1056/NEJM197206012862203. [DOI] [PubMed] [Google Scholar]
  10. Fu S. M., Winchester R. J., Kunkel H. G. The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J Exp Med. 1975 Nov 1;142(5):1334–1338. doi: 10.1084/jem.142.5.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gerber P., Lucas S., Nonoyama M., Perlin E., Goldstein L. I. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet. 1972 Nov 11;2(7785):988–989. doi: 10.1016/s0140-6736(72)92402-6. [DOI] [PubMed] [Google Scholar]
  13. Greaves M. F., Brown G. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis. Clin Immunol Immunopathol. 1975 Mar;3(4):514–524. doi: 10.1016/0090-1229(75)90076-8. [DOI] [PubMed] [Google Scholar]
  14. Greaves M. F., Brown G., Rapson N. T., Lister T. A. Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol. 1975 May;4(1):67–84. doi: 10.1016/0090-1229(75)90041-0. [DOI] [PubMed] [Google Scholar]
  15. Halterman R. H., Leventhal B. G., Mann D. L. An acute-leukemia antigen: correlation with clinical status. N Engl J Med. 1972 Dec 21;287(25):1272–1274. doi: 10.1056/NEJM197212212872504. [DOI] [PubMed] [Google Scholar]
  16. Harris R. Leukaemia antigens and immunity in man. Nature. 1973 Jan 12;241(5385):95–100. doi: 10.1038/241095a0. [DOI] [PubMed] [Google Scholar]
  17. Harris R., Viza D., Todd R., Phillips J., Sugar R., Jennison R. F., Marriott G., Gleeson M. H. Detection of human leukaemia associated antigens in leukaemic serum and normal embryos. Nature. 1971 Oct 22;233(5321):556–557. doi: 10.1038/233556a0. [DOI] [PubMed] [Google Scholar]
  18. Henle W., Henle G. Epstein-Barr virus and infectious mononucleosis. N Engl J Med. 1973 Feb 1;288(5):263–264. doi: 10.1056/NEJM197302012880512. [DOI] [PubMed] [Google Scholar]
  19. Hsu C. C., Chen Y., Patterson R. Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease. Clin Exp Immunol. 1976 Dec;26(3):431–440. [PMC free article] [PubMed] [Google Scholar]
  20. Hsu C. C., Marti G. E., Schrek R., Williams R. C., Jr Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia. Clin Immunol Immunopathol. 1975 Jan;3(3):385–395. doi: 10.1016/0090-1229(75)90026-4. [DOI] [PubMed] [Google Scholar]
  21. Jondal M., Klein G. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med. 1973 Dec 1;138(6):1365–1378. doi: 10.1084/jem.138.6.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klein G. The Epstein-Barr virus and neoplasia. N Engl J Med. 1975 Dec 25;293(26):1353–1357. doi: 10.1056/NEJM197512252932607. [DOI] [PubMed] [Google Scholar]
  23. Klein G. Tumor antigens. Annu Rev Microbiol. 1966;20:223–252. doi: 10.1146/annurev.mi.20.100166.001255. [DOI] [PubMed] [Google Scholar]
  24. Mann D. L., Abelson L., Harris S., Amos D. B. Detection of antigens specific for B-lymphoid cultured cell lines with human alloantisera. J Exp Med. 1975 Jul 1;142(1):84–89. doi: 10.1084/jem.142.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mann D. L., Abelson L., Henkart P., Harris S. D., Amos D. B. Specific human B lymphocyte alloantigens linked to HL-A. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5103–5106. doi: 10.1073/pnas.72.12.5103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mann D. L., Rogentine G. N., Halterman R., Leventhal B. Detection of an antigen associated with acute leukemia. Science. 1971 Dec 10;174(4014):1136–1137. doi: 10.1126/science.174.4014.1136. [DOI] [PubMed] [Google Scholar]
  27. Metzgar R. S., Mohanakumar T., Miller D. S. Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science. 1972 Dec 1;178(4064):986–988. doi: 10.1126/science.178.4064.986. [DOI] [PubMed] [Google Scholar]
  28. Miller G., Niederman J. C., Andrews L. L. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med. 1973 Feb 1;288(5):229–232. doi: 10.1056/NEJM197302012880503. [DOI] [PubMed] [Google Scholar]
  29. Mohanakumar T., Metzgar R. S., Miller D. S. Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst. 1974 May;52(5):1435–1444. doi: 10.1093/jnci/52.5.1435. [DOI] [PubMed] [Google Scholar]
  30. Nilsson K., Pontén J. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer. 1975 Feb 15;15(2):321–341. doi: 10.1002/ijc.2910150217. [DOI] [PubMed] [Google Scholar]
  32. Pellegrino M. A., Ferrone S., Natali P. G., Pellegrino A., Reisfeld R. A. Expression of HL-A antigens in synchronized cultures of human lymphocytes. J Immunol. 1972 Feb;108(2):573–576. [PubMed] [Google Scholar]
  33. Rosenfeld C., Doré J. F., Choquet C., Venuat A. M., Ajuria E., Marholev L., Wastiaux J. P. Variations in expression of cell membrane antigens by cultured cells. A study of antilymphocytic globulin binding by human lymphoblastoid cells before, during, and after their establishment as cell lines. Transplantation. 1973 Oct;16(4):279–286. doi: 10.1097/00007890-197310000-00002. [DOI] [PubMed] [Google Scholar]
  34. Silvestre D., Kourilsky F. M., Klein G., Yata Y., Neauport-Sautes C., Levy J. P. Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling. Int J Cancer. 1971 Sep 15;8(2):222–233. doi: 10.1002/ijc.2910080206. [DOI] [PubMed] [Google Scholar]
  35. Stryckmans P., Delalieux G., Manaster J., Socquet M. The potentiality of out-of-cycle acute leukemic cells to synthesize DNA. Blood. 1970 Dec;36(6):697–703. [PubMed] [Google Scholar]
  36. Viza D., Davies D. A., Harris R. Solubilization and partial purification of human leukaemic specific antigens. Nature. 1970 Sep 19;227(5264):1249–1251. doi: 10.1038/2271249a0. [DOI] [PubMed] [Google Scholar]
  37. Viza D. Immunological aspects of human leukaemia. Ser Haematol. 1972;5(5):87–108. [PubMed] [Google Scholar]
  38. Winchester R. J., Wernet P., Kunkel H. G., Dupont B., Jersild C., Fu S. M. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med. 1975 Apr 1;141(4):924–929. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES